2022 annual financial data
Dermata Therapeutics 2022 Net income growth
Direct answer
Net income growth was -20.92%.
Operating income was -9,674,486 USD and net income was -9,610,913 USD.
Operating cash flow was -8,834,164 USD.
Get free Dermata Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -9,674,486 USD
- Net income
- -9,610,913 USD
- Operating cash flow
- -8,834,164 USD